GE HealthCare (GEHC) Tops Q2 EPS by 9c, Beats on Revenue; Reaffirms Guidance

Go back to GE HealthCare (GEHC) Tops Q2 EPS by 9c, Beats on Revenue; Reaffirms Guidance

GE HealthCare reports second quarter 2026 financial results

July 29, 2026 6:20 AM EDT

Revenue growth of 5.7%, and Organic revenue growth* of 3.5% Record organic orders growth of 11.1%, book-to-bill of 1.15 times and backlog of $23.9 billion Net income margin of 10.6% and Adjusted earnings before interest and taxes (EBIT) margin* of 14.2%; diluted earnings per share (EPS) of $1.24 grew 16.5% and Adjusted EPS* of $1.13 grew 6.6% Cash flow from operating activities of $168 million and Free cash flow* of $68 million Reaffirms full-year 2026 guidance

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today reported financial results for the second quarter ended June 30, 2026.

GE... More